Linden Advisors’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Linden Advisors’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,240,842	Closed	-$2.95M	–	805
2021 Q4	$2.95M	Hold	1,240,842	–	–	0.02%	397
2021 Q3	$5.14M	Hold	1,240,842	–	–	0.03%	294
2021 Q2	$4.64M	Buy	+1,240,842	New	+$5.6M	0.02%	354

Other funds holding CANO.WS

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Linden Advisors's CANO.WS Position: Q1 2022 in Review

Linden Advisors sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q1 2022, closing a stake of 1,240,842 shares — an estimated $2.95M sold.

Linden Advisors first reported a position in CANO.WS in Q2 2021 and held it in 3 quarters. The position peaked at $5.14M in Q3 2021. 29 funds tracked by Wall St. Rank hold CANO.WS as of Q1 2022.

Linden Advisors reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q1 2022 after selling out during the quarter.
Linden Advisors sold 1,240,842 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q1 2022, an estimated $2.95M.
Linden Advisors first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 3 quarters.
Linden Advisors's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $5.14M in Q3 2021.
29 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.